Skip to content

Clinical trials

Phase 1 Sarcoma trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sarcoma Phase: Phase 1 Country / region: France Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20111
20121
20163
20172
20181
20201
20212
20221
20231
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting4
Terminated4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company3
Hoffmann-La Roche2
Institut Bergonié2
ADC Therapeutics S.A.1
Daiichi Sankyo1
EMD Serono Research & Development Institute, Inc.1
Foghorn Therapeutics Inc.1
IGM Biosciences, Inc.1
Inhibrx Biosciences, Inc1
Institut Claudius Regaud1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sarcoma17
Breast Neoplasms2
Colorectal Neoplasms2
Neoplasm Metastasis2
Sarcoma, Synovial2
Carcinoma, Non-Small-Cell Lung1
Carcinoma, Renal Cell1
Cholangiocarcinoma1
Chondrosarcoma1
Colonic Neoplasms1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.